Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients with Crohn’s Disease

BACKGROUND & AIMS: As more treatment options for inflammatory bowel diseases become available, it is important to identify patients most likely to respond to different therapies. We created and validated a scoring system to identify patients with Crohn’s disease (CD) who respond to vedolizumab....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gastroenterology
Egile Nagusiak: Dulai, Parambir S., Boland, Brigid S., Singh, Siddharth, Chaudrey, Khadija, Koliani-Pace, Jenna L., Kochhar, Gursimran, Parikh, Malav P., Shmidt, Eugenia, Hartke, Justin, Chilukuri, Prianka, Meserve, Joseph, Whitehead, Diana, Hirten, Robert, Winters, Adam C., Katta, Leah G., Peerani, Farhad, Narula, Neeraj, Sultan, Keith, Swaminath, Arun, Bohm, Matthew, Lukin, Dana, Hudesman, David, Chang, John T., Rivera-Nieves, Jesus, Jairath, Vipul, Zou, GY, Feagan, Brian G., Shen, Bo, Siegel, Corey A., Loftus, Edward V., Kane, Sunanda, Sands, Bruce E., Colombel, Jean-Frederic, Sandborn, William J., Lasch, Karen, Cao, Charlie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419724/
https://ncbi.nlm.nih.gov/pubmed/29857091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2018.05.039
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak